Two Biologics Show No Difference in Axial Spondyloarthritis

This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at high risk for radiographic progression.
Medscape Medical News

source https://www.medscape.com/viewarticle/992645?src=rss

Comments

Post a Comment

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Rheumatoid arthritis increased the risk for lung cancer, and this risk was threefold higher in patients with rheumatoid arthritis–associated interstitial lung disease. Medscape Medical News source https://www.medscape.com/viewarticle/rheumatoid-arthritis-and-ra-associated-interstitial-lung-2024a1000epm?src=rss
Read more

A case report of pudendal arteries angioplasty with sirolimus drug-coated balloon and drug-eluting stent associated with intracavernous autologous peripheral blood mononuclear cells injection for untreatable vasculogenic erectile dysfunction.

Erectile dysfunction (ED) is a prevalent health problem that seriously impacts men’s quality of life. The potential treatment of ED by percutaneous approach has emerged with valid angiographic results and a significant improvement in symptoms and quality of life. In addition, cell-based regenerative therapies aiming at enhancing neovascularization have been successfully performed with peripheral blood mononuclear cells (PBMNCs) in diabetic patients affected by critical limb ischaemia. We report a case of a young insulin dependent (ID) diabetic patients who suffered of severe vasculogenic erectile dysfunction associated with a poor response for more than 1 year to oral phosphodiesterase-5 inhibitors (PDE5i) and intracavernous (IC) phosphodiesterase type 1 (PDE1) therapy. At selective angiography of the pelvic district, a severe atherosclerotic disease of the internal iliac and pudendal artery was evident with absence of distal vascularization of the cavernous bodies. The patient was tr...
Read more